Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity

PURPOSE: We tested the efficacy and toxicity of cisplatin plus accelerated fractionation with a concomitant boost (AFX-C) versus standard fractionation (SFX) in locally advanced head and neck carcinoma (LA-HNC). PATIENTS AND METHODS: Patients had stage III to IV carcinoma of the oral cavity, orophar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Nguyen-Tan, Phuc Felix, Zhang, Qiang, Ang, K. Kian, Weber, Randal S., Rosenthal, David I., Soulieres, Denis, Kim, Harold, Silverman, Craig, Raben, Adam, Galloway, Thomas J., Fortin, André, Gore, Elizabeth, Westra, William H., Chung, Christine H., Jordan, Richard C., Gillison, Maura L., List, Marcie, Le, Quynh-Thu
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2014
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4239304/
https://ncbi.nlm.nih.gov/pubmed/25366680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.55.3925
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados